NTSR2
Basic information
Region (hg38): 2:11658178-11670195
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NTSR2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 20 | 24 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 20 | 6 | 1 |
Variants in NTSR2
This is a list of pathogenic ClinVar variants found in the NTSR2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-11658496-G-T | not specified | Uncertain significance (May 21, 2024) | ||
2-11658548-C-T | Likely benign (Jul 01, 2022) | |||
2-11658558-C-T | not specified | Uncertain significance (Dec 14, 2021) | ||
2-11658559-G-A | not specified | Uncertain significance (Feb 23, 2023) | ||
2-11658595-C-T | not specified | Uncertain significance (Jun 04, 2024) | ||
2-11658596-G-A | not specified | Likely benign (Sep 19, 2023) | ||
2-11658640-A-G | not specified | Uncertain significance (Sep 25, 2023) | ||
2-11660052-G-A | not specified | Uncertain significance (Dec 02, 2022) | ||
2-11660056-C-T | not specified | Uncertain significance (Mar 29, 2022) | ||
2-11660119-T-C | not specified | Likely benign (Jun 10, 2022) | ||
2-11660125-C-T | not specified | Uncertain significance (Jun 27, 2023) | ||
2-11661984-C-T | not specified | Likely benign (Sep 14, 2022) | ||
2-11662005-C-T | not specified | Uncertain significance (Jan 08, 2024) | ||
2-11662020-C-T | Benign (Apr 04, 2018) | |||
2-11662108-G-T | Likely benign (Apr 04, 2018) | |||
2-11662128-G-A | not specified | Likely benign (Apr 22, 2024) | ||
2-11662213-G-A | not specified | Uncertain significance (Mar 11, 2024) | ||
2-11669541-G-C | not specified | Uncertain significance (Jan 24, 2023) | ||
2-11669609-A-G | not specified | Uncertain significance (Jul 20, 2021) | ||
2-11669673-G-A | not specified | Uncertain significance (Sep 22, 2023) | ||
2-11669690-A-G | not specified | Uncertain significance (Jun 26, 2023) | ||
2-11669815-G-C | not specified | Uncertain significance (Mar 02, 2023) | ||
2-11669837-T-C | not specified | Uncertain significance (May 24, 2023) | ||
2-11669842-C-A | not specified | Uncertain significance (Jun 13, 2022) | ||
2-11669938-G-T | Likely benign (Jul 01, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NTSR2 | protein_coding | protein_coding | ENST00000306928 | 4 | 11987 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00487 | 0.892 | 125692 | 1 | 44 | 125737 | 0.000179 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.635 | 203 | 230 | 0.882 | 0.0000144 | 2550 |
Missense in Polyphen | 47 | 63.07 | 0.74521 | 813 | ||
Synonymous | 0.616 | 103 | 111 | 0.926 | 0.00000751 | 916 |
Loss of Function | 1.39 | 5 | 9.66 | 0.517 | 4.87e-7 | 105 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00116 | 0.00116 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000594 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000176 | 0.0000176 |
Middle Eastern | 0.0000594 | 0.0000544 |
South Asian | 0.000229 | 0.000196 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Receptor for the tridecapeptide neurotensin. It is associated with G proteins that activate a phosphatidylinositol- calcium second messenger system.;
- Pathway
- Neuroactive ligand-receptor interaction - Homo sapiens (human);Peptide GPCRs;GPCRs, Class A Rhodopsin-like;Signaling by GPCR;Signal Transduction;Peptide ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding;G alpha (q) signalling events;GPCR downstream signalling
(Consensus)
Recessive Scores
- pRec
- 0.111
Haploinsufficiency Scores
- pHI
- 0.136
- hipred
- N
- hipred_score
- 0.324
- ghis
- 0.459
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.287
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ntsr2
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan);
Gene ontology
- Biological process
- cell surface receptor signaling pathway;G protein-coupled receptor signaling pathway;phospholipase C-activating G protein-coupled receptor signaling pathway;neuropeptide signaling pathway;sensory perception;regulation of membrane potential
- Cellular component
- plasma membrane;integral component of plasma membrane
- Molecular function
- G protein-coupled receptor activity;G protein-coupled neurotensin receptor activity